109 related articles for article (PubMed ID: 7700912)
21. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
[No Abstract] [Full Text] [Related]
22. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
23. Cryopreservation of human bone marrow after purging T-cells or tumor cells.
Zhang ZX; Xu YJ; Chen Y; Li Y; Shen BF; Bai Y
Cryobiology; 1994 Oct; 31(5):478-82. PubMed ID: 7988157
[TBL] [Abstract][Full Text] [Related]
24. Potential of phenylalanine methylester as a bone marrow purging agent.
Rosenfeld CS
Blood; 1992 Nov; 80(9):2401-5. PubMed ID: 1384802
[TBL] [Abstract][Full Text] [Related]
25. Use and mechanism of action of AS101 in protecting bone marrow colony forming units-granulocyte-macrophage following purging with ASTA-Z 7557.
Kalechman Y; Barkai IS; Albeck M; Horwith G; Sehagl SN; Sredni B
Cancer Res; 1991 Oct; 51(20):5614-20. PubMed ID: 1913679
[TBL] [Abstract][Full Text] [Related]
26. Purging multidrug resistant cells from bone marrow.
Chao NJ; Aihara M; Kühl JS; Sikic BI; Blume KG
Prog Clin Biol Res; 1992; 377():13-23. PubMed ID: 1438409
[No Abstract] [Full Text] [Related]
27. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
Linker CA; Ries CA; Damon LE; Rugo HS; Wolf JL
Bone Marrow Transplant; 1998 Nov; 22(9):865-72. PubMed ID: 9827814
[TBL] [Abstract][Full Text] [Related]
28. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
[TBL] [Abstract][Full Text] [Related]
29. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
Damon LE; Rugo HS; Ries CA; Linker CA
Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
[TBL] [Abstract][Full Text] [Related]
30. Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycin.
Visani G; Rizzoli V; Dinota A; Aglietta M; Bernabei PA; Geraci L; Leoni P; Mangoni L; Meloni G; Motta MR
Haematologica; 1988; 73(3):179-81. PubMed ID: 2458996
[No Abstract] [Full Text] [Related]
31. [Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line].
Olivieri A; Masia C; Centurioni R; Montillo M; Leoni P
Boll Soc Ital Biol Sper; 1986 Feb; 62(2):211-8. PubMed ID: 2424481
[No Abstract] [Full Text] [Related]
32. Survival of rat bone marrow cells after treatment with myleran and endoxan.
Dunjic A; Cuvelier AM
Exp Hematol; 1973; 1(1):11-21. PubMed ID: 4608438
[No Abstract] [Full Text] [Related]
33. Hematopoietic response after treatment with cyclophosphamide and autotransplantation of non-damaged bone marrow cells.
Ninkov V; Piletić O
Acta Biol Med Ger; 1974; 33(1):35-41. PubMed ID: 4609244
[No Abstract] [Full Text] [Related]
34. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
Yamazaki T; Sato Y; Sieber F
Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
[TBL] [Abstract][Full Text] [Related]
35. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
36. Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients.
Manna M; Nesci S; Andreani M; Tonucci P; Lucarelli G
Bone Marrow Transplant; 1993; 12 Suppl 1():70-3. PubMed ID: 8104074
[No Abstract] [Full Text] [Related]
37. Negative selection and protection of normal progenitor cells for autografting.
Douay L
Bone Marrow Transplant; 1998 Sep; 22(5):423-30. PubMed ID: 9733264
[TBL] [Abstract][Full Text] [Related]
38. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells.
Uckun FM; Gajl-Peczalska K; Meyers DE; Ramsay NC; Kersey JH; Colvin M; Vallera DA
Blood; 1987 Jan; 69(1):361-6. PubMed ID: 3098325
[TBL] [Abstract][Full Text] [Related]
39. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement.
Bird JM; Luger S; Mangan P; Edelstein M; Silberstein L; Powlis W; Ball J; Schultz DJ; Stadtmauer EA
Bone Marrow Transplant; 1996 Aug; 18(2):309-13. PubMed ID: 8864439
[TBL] [Abstract][Full Text] [Related]
40. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
